好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Distinguishing tremor components in Essential Tremor: a digital spirography study
Movement Disorders
P4 - Poster Session 4 (5:30 PM-6:30 PM)
10-032
Enhancing understanding of spirals as a measurement of tremor.

Archimedes spirals have been widely used to quantify clinically meaningful action tremor along with being a part of The Essential Tremor Rating Assessment Scale (TETRAS) scale. It is common to see a variation in tremor between the beginning and end of a spiral as noted during data analysis. Understanding the cause of these separate spiral components could lead to more specific clinical use and interpretation of spirals. 

Patients with Essential Tremor (ET) drew multiple spirals on a digitizing tablet in our clinic along with performance of TETRAS. Time-frequency analysis was performed using wavelet analysis, comparing the first loop of the spiral (short segment) with the remaining segment of the spiral (long segment). The amplitude and frequency of the largest peak was extracted for analysis.  The results were correlated with TETRAS scale. In addition, some subjects were studied with EMG and accelerometers.

There was a high correlation in the power of the tremor at peak frequency between the short segment vs/ the rest of the spiral (r=0.98, p <0.001). Both the short and the long segment of the spirals show a significant correlation with total TETRAS scale, (R=0.59, p <0.001, R=0.53, p<0.001). Additionally, 63.4% of the subjects show two non-harmonic peaks in spirals for both short and long segments, with median peaks 5Hz and 7Hz. 

There is a significant correlation between the TETRAS score and the power of the peak of the tremor of both the initial segment and the rest of the spiral, with no significant difference between them. The two peaks observed on most of the spirals in the frequency domain may correspond to distinct presentations of action tremor, namely postural as well as kinetic tremor. We will also use EMG and accelerometry results to further study the two peaks.

 

Authors/Disclosures
Thomas Osterholt
PRESENTER
No disclosure on file
Felipe Vial, MD No disclosure on file
Mark Hallett, MD, FAAN (National Institutes of Health) Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Dietrich Haubenberger, MD, FAAN (Neurocrine Biosciences) Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.